Systematic identification of the interventional mechanism of Qingfei Xiaoyan Wan (QFXYW) in treatment of the cytokine storm in acute lung injury using transcriptomics-based system pharmacological analyses
Context Acute lung injury (ALI) is a complex, severe inflammation disease with high mortality, and there is no specific and effective treatment for ALI. Qingfei Xiaoyan Wan (QFXYW) has been widely used to treat lung-related diseases for centuries.Objective This study evaluates the potential effects...
Saved in:
Main Authors: | Jing-Yi Hou (Author), Jia-Rong Wu (Author), Yi-Bing Chen (Author), Dong Xu (Author), Shu Liu (Author), Dan-dan Shang (Author), Guan-Wei Fan (Author), Yuan-Lu Cui (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Qingfei Xiaoyan Wan, a traditional Chinese medicine formula, ameliorates Pseudomonas aeruginosa-induced acute lung inflammation by regulation of PI3K/AKT and Ras/MAPK pathways
by: Yuanyuan Hou, et al.
Published: (2016) -
Clinical efficacy evaluation and potential mechanism prediction on Pudilan Xiaoyan oral liquid in treatment of mumps in children based on meta-analysis, network pharmacology, and molecular docking
by: Yi Liu, et al.
Published: (2022) -
Weathering a Cytokine Storm
by: Tiffany Y. Shaw MD, et al.
Published: (2016) -
The Management of Cytokine Storm in COVID-19
by: Cleopas Martin Rumende, et al.
Published: (2020) -
Calming the Storm: Natural Immunosuppressants as Adjuvants to Target the Cytokine Storm in COVID-19
by: Angela E. Peter, et al.
Published: (2021)